Arbor Pharmaceuticals Announces the Launch of ZINOTIC ES - A New Extra Strength Product for the Treatment of Acute Otitis Externa

cicugaha.wordpress.com
June 2 /PRNewswire/ -- Arbor Pharmaceuticals a specialty pharmaceutical company focuseds exclusively onpediatric medicine, announcedx today that the company has launched ZINOTICd ES as a new treatmenf option for Acute Otitis Externa (AOE). ZINOTIC ES is an extrz strength formulation of original ZINOTIC intended to provide childrenn suffering from AOE with a greatere degree of pain relief and skin ZINOTIC ES is Arbor Pharmaceuticals fourth product launch inthe U.S. and is now availablew by prescription from retail pharmacies acrossthe U.S. AOE or "swimmer'as ear" is a common childhood infection of the ear canal characterized by intense pain and damaged skin.
Children are most susceptible to AOE, and swimming is the most common predisposing factor for acquirinhgthe infection. When treating AOE therew are three main goals to address includintg treatingthe infection, relieving the pain and restoring the integrity of the liningf of the ear canal. ZINOTIf is the only family of products that addresses the thre e AOEtreatment goals. ZINOTIC ES contains the maximuk dose of pramoxine and a higher levek of zinc acetate to enable greatet pain relief and skin protection whiles treating the infection withoutan antibiotic.
"ZINOTIC has becomr an important AOE treatment optioj sinceits introduction, and new ZINOTIC ES will be a welcomse addition to the ZINOTIC franchise as it further addresses the three AOE treatment goalws with its enhanced, extra strengtu formulation," according to , President and CEO of Arbor "The launch of ZINOTIC ES demonstrates the company'es ongoing dedication to enhancing pediatric medicine. Arbof will continue to build its portfoliol of pediatric pharmaceuticals focuse on providing novel prescription products for the most commonbpediatric illnesses." ZINOTIC ES is being promotede to U.S.
pediatricians by Arbor Pharmaceuticals' salex force and via partneer companies in select regionse ofthe U.S. For more information abou ZINOTIC ES, visit . The most common side effects ofpramoxinee (contained in ZINOTIC ES) includd redness, irritation, swelling, burning, stinging, pain or dryness at the affected area. Arbor Pharmaceuticals is a North Carolina-based specialty pharmaceuticak company focused exclusively on the growinhgpediatric market. The company is well positioned to becoms theleading pediatrics-focused pharmaceutical companyg by actively licensing, developingt and commercializing late-stage products for common pediatric conditions.
The company currently focuses on nonantibiotif products for ear infections including ZINOTIC for acutdeotitis externa, XYLAREX for the dietary management of recurrent ear infectiona and NEOTIC for acute otitias media. Arbor is also buildinvg a pipeline of other promising product s for the most commonpediatric illnesses. To learm more about Arbor Pharmaceuticals, visit or send emai inquiries to .